Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism

Supriya Shah(University of Pennsylvania), Kathryn E. Wellen(Cancer Research Institute)
Oncotarget
May 27, 2016
Cited by 80


Related Papers